Literature DB >> 22229148

Ultrasonography-guided peripheral intravenous catheter in emergency department patients with difficult access.

Luciano Santana-Cabrera1, Guillermo Pérez-Acosta, Sergio Martínez-Cuéllar, Manuel Sánchez-Palacios.   

Abstract

Entities:  

Year:  2011        PMID: 22229148      PMCID: PMC3249856          DOI: 10.4103/2229-5151.84812

Source DB:  PubMed          Journal:  Int J Crit Illn Inj Sci        ISSN: 2229-5151


× No keyword cloud information.
Sir, Emergency nurses (ENs) place peripheral intravenous (IV) lines, but if repeated attempts fail, emergency physicians have to obtain peripheral or central access. Some patients such as those who are obese, chronically ill, hypovolemic, IV drug users, or those with vascular pathology may prove exceedingly difficult for peripheral IV placement. Several studies have evaluated the use of ultrasound (US) guidance for central venous access.[12] Also,this technique has been applied by peripheral vein brachial and basilic veinchanneling by doctors and nurses in emergency department (ED) patients showing aconsiderable profit.[3-5] These studies have evaluated US-guided peripheral IV line placement in a group of ED patients, the majority of whom were IV drug users or significantly obese. The lines were placed by emergency physicians with a reported success rate of > 90%.[3] These studies involved emergency physicians using US to place peripheral lines even though the initial attempts were made by the nursing staff. With this method the only complication is arterial puncture and nerve contact, and only a very small percentage of patients require a central line.[4] However, placement of a central line is associated with a greater than 15% rate of significant complications, including arterial puncture, pneumothorax, deep vein thrombosis and infection.[5] Our experience is limited, but this is of higher quality when inserting catheters, (less time, a more direct technique, fewer attempts), particularly in overweight patients withedema when vascular access is very limited [Figure 1].
Figure 1

Entry via cephalic catheter (arrow)

Entry via cephalic catheter (arrow) Therefore, in patients with difficult access who are admitted to an intensive care setting or in whom there is a high potential for clinical deterioration, it may be prudent to consider placing a central line rather than attempting US-guided peripheral IV access in the ED. Although the percentage of difficult-access patients who go on to receive a central line probably varies from one ED to another. In conclusion, US-guided peripheral IV access is more successful than traditional "blind" techniques, requires less time, decreases the number of percutaneous punctures, and improves patient satisfaction in the group of patients who have difficult intravenous access.
  5 in total

1.  Ultrasonography-guided peripheral intravenous catheter survival in ED patients with difficult access.

Authors:  James M Dargin; Casey M Rebholz; Robert A Lowenstein; Patricia M Mitchell; James A Feldman
Journal:  Am J Emerg Med       Date:  2010-01       Impact factor: 2.469

2.  Ultrasound-assisted internal jugular vein catheterization in the ED.

Authors:  P Hrics; S Wilber; M P Blanda; U Gallo
Journal:  Am J Emerg Med       Date:  1998-07       Impact factor: 2.469

3.  Ultrasound-guided brachial and basilic vein cannulation in emergency department patients with difficult intravenous access.

Authors:  L E Keyes; B W Frazee; E R Snoey; B C Simon; D Christy
Journal:  Ann Emerg Med       Date:  1999-12       Impact factor: 5.721

4.  Ultrasonography-guided peripheral intravenous access versus traditional approaches in patients with difficult intravenous access.

Authors:  Thomas G Costantino; Aman K Parikh; Wayne A Satz; John P Fojtik
Journal:  Ann Emerg Med       Date:  2005-11       Impact factor: 5.721

5.  Ultrasound guidance versus the landmark technique for the placement of central venous catheters in the emergency department.

Authors:  Adam H Miller; Brett A Roth; Trevor J Mills; Jay R Woody; Charles E Longmoor; Barbara Foster
Journal:  Acad Emerg Med       Date:  2002-08       Impact factor: 3.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.